From oil infused face masks to chocolate edibles, CBD products are popping up everywhere. CBD oil products have gained popularity because they are believed to provide relief for inflammation, pain, anxiety, psychosis, seizures and, spasms. This article takes a deeper look into the scientific basis to these claims.
What is CBD oil?
Cannabidiol, popularly known as CBD, is one of the chemical compounds found in the cannabis sativa or marijuana plant. 2018 has seen a sudden rise in CBD oil products like chocolate, snacks, and supplements. This is probably due to the increased number of people voting to legalize recreational marijuana.
Tetrahydrocannabinol (THC) is another compound found in cannabis and is responsible for the sensation of getting “high.” CBD oil on the hand is not psychoactive.
What does the science say?
Anxiety: CBD oil has been shown to reduce anxiety, discomfort and, cognitive impairment in people with Generalized Social Anxiety Disorder. The ability of CBD to reduce anxiety has also been observed in several animal models.(1)
Inflammation: Research on rats shows that CBD interacts with neurotransmitters and may lower inflammation and chronic pain.(2)
Cancer Related Side-Effects: Chemotherapy is known to have adverse effects on patients with side effects like nausea and vomiting. Some studies have found that taking CBD can significantly lower these side effects.(3)
Heart Health: Studies have found that by reducing oxidative stress and inflammation, CBD has the potential to treat diabetic complications and other cardiovascular disorders.(4)
CBD is generally well tolerated but side effects like vomiting, dizziness and nausea are possible. CBD is currently not approved by the United States FDA. Additionally, it is always best to speak with your doctor before using CBD to check for possible drug interactions.
Ragland, J. Daniel. "Faculty of 1000 Evaluation for Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-naïve Social Phobia Patients."F1000 - Post-publication Peer Review of the Biomedical Literature, 2018. doi:10.3410/f.720452506.793545378.
Genaro, Karina, Débora Fabris, Ana L. F. Arantes, Antônio W. Zuardi, José A. S. Crippa, and Wiliam A. Prado. "Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats."Frontiers in Pharmacology 8 (2017). doi:10.3389/fphar.2017.00391.
Bloechl-Daum, Brigitte, Robert R. Deuson, Panagiotis Mavros, Mogens Hansen, and Jørn Herrstedt. "Delayed Nausea and Vomiting Continue to Reduce Patients Quality of Life After Highly and Moderately Emetogenic Chemotherapy Despite Antiemetic Treatment."Journal of Clinical Oncology 24, no. 27 (2006): 4472-478. doi:10.1200/jco.2006.05.6382.
Rajesh, Mohanraj, Partha Mukhopadhyay, Sándor Bátkai, Vivek Patel, Keita Saito, Shingo Matsumoto, Yoshihiro Kashiwaya, Béla Horváth, Bani Mukhopadhyay, Lauren Becker, György Haskó, Lucas Liaudet, David A. Wink, Aristidis Veves, Raphael Mechoulam, and Pál Pacher. "Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy."Journal of the American College of Cardiology 56, no. 25 (2010): 2115-125. doi:10.1016/j.jacc.2010.07.033.